JP2010523620A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523620A5
JP2010523620A5 JP2010502504A JP2010502504A JP2010523620A5 JP 2010523620 A5 JP2010523620 A5 JP 2010523620A5 JP 2010502504 A JP2010502504 A JP 2010502504A JP 2010502504 A JP2010502504 A JP 2010502504A JP 2010523620 A5 JP2010523620 A5 JP 2010523620A5
Authority
JP
Japan
Prior art keywords
formula
compound
enantiomeric excess
weight
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502504A
Other languages
English (en)
Japanese (ja)
Other versions
JP5635905B2 (ja
JP2010523620A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/054316 external-priority patent/WO2008125578A2/en
Publication of JP2010523620A publication Critical patent/JP2010523620A/ja
Publication of JP2010523620A5 publication Critical patent/JP2010523620A5/ja
Application granted granted Critical
Publication of JP5635905B2 publication Critical patent/JP5635905B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502504A 2007-04-11 2008-04-10 ミルタザピンの調製方法 Active JP5635905B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07105985 2007-04-11
EP07105985.1 2007-04-11
PCT/EP2008/054316 WO2008125578A2 (en) 2007-04-11 2008-04-10 A method for the preparation of mirtazapine

Publications (3)

Publication Number Publication Date
JP2010523620A JP2010523620A (ja) 2010-07-15
JP2010523620A5 true JP2010523620A5 (en:Method) 2011-05-26
JP5635905B2 JP5635905B2 (ja) 2014-12-03

Family

ID=38474342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502504A Active JP5635905B2 (ja) 2007-04-11 2008-04-10 ミルタザピンの調製方法

Country Status (8)

Country Link
EP (1) EP2146993B1 (en:Method)
JP (1) JP5635905B2 (en:Method)
CN (1) CN101679431B (en:Method)
AR (1) AR066005A1 (en:Method)
CA (1) CA2684021A1 (en:Method)
MX (1) MX2009010967A (en:Method)
WO (1) WO2008125578A2 (en:Method)
ZA (1) ZA200907537B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG191831A1 (en) * 2011-03-31 2013-08-30 Kaneka Corp Process for preparing cyclic amine compounds
HRP20211040T1 (hr) 2015-02-27 2021-10-01 Dechra Limited Poticanje apetita, upravljanje gubitkom težine, i liječenje anoreksije kod pasa i mačaka
CN121204204A (zh) * 2025-11-27 2025-12-26 山东静远药业有限公司 一种苯磺酸米洛巴林关键中间体的对映体杂质的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
BR9815098A (pt) 1997-11-14 2000-10-10 Akzo Nobel Nv Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.
KR20020019902A (ko) 1999-04-19 2002-03-13 추후보정 피페라진 고리 함유 화합물의 신규한 합성법 및 결정화법
AU6476300A (en) 1999-09-30 2001-05-10 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a piperazine derivative
AU6474200A (en) 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
EP1658850A1 (en) 2000-02-11 2006-05-24 Akzo Nobel N.V. The use of mirtazapine for the treatment of sleep disorders
WO2003024918A1 (es) 2001-09-14 2003-03-27 Medichem S.A. Compuestos intermedios para la preparación de mirtazapina y sus procedimientos de obtención
US6806283B2 (en) * 2002-05-06 2004-10-19 Virginia Commonwealth University Selective serotonin receptor antagonists and therapeutic applications thereof
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
PL1651658T5 (pl) * 2003-08-01 2020-11-30 Mitsubishi Tanabe Pharma Corporation Nowe związki o działaniu inhibitującym transporter zależny od sodu
JP2007284358A (ja) 2006-04-13 2007-11-01 Sumitomo Chemical Co Ltd 光学活性なピペラジン化合物の製造方法
TW200815370A (en) * 2006-06-16 2008-04-01 Organon Nv Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine

Similar Documents

Publication Publication Date Title
JP2010174033A5 (en:Method)
JP2010528043A5 (en:Method)
WO2011146820A3 (en) Process for cis-1,1,1,4,4,4,-hexafluoro-2-butene
JP2009138000A5 (en:Method)
JP5628427B2 (ja) ロスバスタチンカルシウム中間物の調製方法
JP2010500343A5 (en:Method)
JP2009137945A5 (en:Method)
JP2010501516A5 (en:Method)
JP2007077384A5 (en:Method)
JP2011524871A5 (en:Method)
JP2013508368A5 (en:Method)
JP2013520495A5 (en:Method)
JP2008526897A5 (en:Method)
JP2014504599A5 (en:Method)
JP2015519354A5 (en:Method)
JP2010536802A5 (en:Method)
JP2010523620A5 (en:Method)
JP2013100237A5 (en:Method)
JP2018506541A5 (en:Method)
JP2011528011A5 (en:Method)
JP2008247919A5 (en:Method)
JP2009235054A5 (en:Method)
JP2018009003A5 (en:Method)
JP2010517998A5 (en:Method)
JP2011513358A5 (en:Method)